Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop
- 31 October 2004
- journal article
- research article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 191 (4), 1240-1246
- https://doi.org/10.1016/j.ajog.2004.03.004
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Regulation of trophoblast invasion: from normal implantation to pre-eclampsiaMolecular and Cellular Endocrinology, 2002
- Serum Levels of Vascular Endothelial Growth Factor in Preeclamptic and Normotensive PregnancyHypertension, 2000
- The effects of vascular endothelial growth factor on endothelial cells: A potential role in preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2000
- Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rateProceedings of the National Academy of Sciences of the United States of America, 1998
- A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy.Human Reproduction, 1998
- Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1Molecular Human Reproduction, 1998
- Endothelial Dysfunction in PreeclampsiaSeminars in Reproductive Medicine, 1998
- Vascular Endothelial Growth Factor Is Increased in Patients With PreeclampsiaAmerican Journal of Reproductive Immunology, 1997
- Angiogenesis and the Expression of Vascular Endothelial Growth Factor in Endometrium and PlacentaAmerican Journal of Reproductive Immunology, 1997
- Pre-eclampsia: more than pregnancy-induced hypertensionThe Lancet, 1993